Coronavirus

Moderna Confirms Its COVID-19 Vaccine Could Be Industry's Most Expensive

Executives from the Cambridge-based company discussed the commercialization plans for its vaccine and other business updates on Wednesday

NBCUniversal, Inc.

Tens of thousands of volunteers will take part in the study, with results being reported as soon as November.

Local biotech firm Moderna Inc. has indicated its COVID-19 vaccine could be one of the most expensive in the industry.

Executives from the Cambridge-based company discussed the commercialization plans for its COVID-19 vaccine, mRNA-1273, and other business updates during the company's second quarter earnings call Wednesday.

There were four key takeaways from the call.

Read more at the Boston Business Journal.

Exit mobile version